These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 10344175)

  • 21. Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals.
    Fleury G; De La Garza R; Mahoney JJ; Evans SE; Newton TF
    Am J Addict; 2008; 17(2):103-10. PubMed ID: 18393052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meth mouth.
    Heng CK; Badner VM; Schiop LA
    N Y State Dent J; 2008; 74(5):50-1. PubMed ID: 18982966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?
    Proebstl L; Kamp F; Koller G; Soyka M
    Pharmacopsychiatry; 2018 Nov; 51(6):243-250. PubMed ID: 29334687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of methamphetamine intoxication and its medical identification].
    Gao WM; Wan Y; Mao RM; Mi L; Du ZB; Cao ZP; Zhu BL
    Fa Yi Xue Za Zhi; 2012 Apr; 28(2):126-9. PubMed ID: 22619810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral health issue brief: treatment of methamphetamine abuse: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-8. PubMed ID: 12875274
    [No Abstract]   [Full Text] [Related]  

  • 27. Methamphetamine use in Dayton, Ohio: preliminary findings from the Ohio Substance Abuse Monitoring Network.
    Daniulaityte R; Carlson RG; Kenne DR
    J Psychoactive Drugs; 2007 Sep; 39(3):211-21. PubMed ID: 18159774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Driving under the influence of amphetamine and metamphetamine].
    Lia K; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):105-8. PubMed ID: 19151802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exploratory study: the use of paroxetine for methamphetamine craving.
    Piasecki MP; Steinagel GM; Thienhaus OJ; Kohlenberg BS
    J Psychoactive Drugs; 2002; 34(3):301-4. PubMed ID: 12422941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurologic manifestations of chronic methamphetamine abuse.
    Rusyniak DE
    Neurol Clin; 2011 Aug; 29(3):641-55. PubMed ID: 21803215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Committee Opinion No. 479: Methamphetamine abuse in women of reproductive age.
    Obstet Gynecol; 2011 Mar; 117(3):751-755. PubMed ID: 21343793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity of amphetamines: an update.
    Carvalho M; Carmo H; Costa VM; Capela JP; Pontes H; Remião F; Carvalho F; Bastos Mde L
    Arch Toxicol; 2012 Aug; 86(8):1167-231. PubMed ID: 22392347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 34. Recipe for disaster: Mexican methamphetamine.
    Dye LR
    J Med Toxicol; 2006 Jun; 2(2):81-2. PubMed ID: 18072120
    [No Abstract]   [Full Text] [Related]  

  • 35. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methamphetamine-associated catatonia: Case series and systematic review of the literature from 1943-2020.
    Slavnic B; Barnett BS; McIntire S; Becker R; Saba S; Vellanki KD; Honaker L; Weleff J; Carroll BT
    Ann Clin Psychiatry; 2023 Aug; 35(3):167-177. PubMed ID: 37459499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine--what primary care practitioners need to know.
    McAvoy BR
    J Prim Health Care; 2009 Sep; 1(3):170-6. PubMed ID: 20690379
    [No Abstract]   [Full Text] [Related]  

  • 38. Manufacturing methamphetamine: medical-psychiatric complications of an illegal act.
    Lazarou EE
    J Psychiatr Pract; 2008 Jul; 14(4):241-5. PubMed ID: 18664894
    [No Abstract]   [Full Text] [Related]  

  • 39. Methamphetamine abuse and "meth mouth".
    Rhodus NL; Little JW
    Northwest Dent; 2005; 84(5):29, 31, 33-7. PubMed ID: 16317979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
    Griffiths P; Mravcik V; Lopez D; Klempova D
    Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.